Search Results - "Meyer, Paul N."
-
1
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Published in Journal of clinical oncology (01-10-2012)“…Diffuse large B-cell lymphoma (DLBCL) is curable in 60% of patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone…”
Get full text
Journal Article -
2
Immunohistochemical Methods for Predicting Cell of Origin and Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
Published in Journal of clinical oncology (10-01-2011)“…Patients with diffuse large B-cell lymphoma (DLBCL) can be divided into prognostic groups based on the cell of origin of the tumor as determined by microarray…”
Get full text
Journal Article -
3
BCL2 Predicts Survival in Germinal Center B-cell―like Diffuse Large B-cell Lymphoma Treated with CHOP-like Therapy and Rituximab
Published in Clinical cancer research (15-12-2011)“…We have previously shown the prognostic significance of BCL2 expression in the activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL) patients treated…”
Get full text
Journal Article -
4
Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults
Published in American journal of clinical pathology (01-07-2007)“…Renal cell carcinomas associated with Xp11.2 translocations ( TFE3 gene fusions) are rare tumors predominantly reported in children. We studied 5 cases of…”
Get full text
Journal Article -
5
The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
Published in American journal of clinical pathology (2011)“…The cellular composition of the tumor microenvironment may affect survival in diffuse large B-cell lymphoma (DLBCL). We performed immunostains for 2 stromal…”
Get full text
Journal Article -
6
A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma
Published in Blood (13-09-2012)“…Biologic factors that predict the survival of patients with a diffuse large B-cell lymphoma, such as cell of origin and stromal signatures, have been…”
Get full text
Journal Article -
7
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome
Published in Leukemia & lymphoma (02-11-2015)“…In this study, we investigated the significance of MYC, BCL2 and BCL6 gene abnormalities in a cohort of 205 diffuse large B-cell lymphoma (DLBCL) patients…”
Get full text
Journal Article -
8
The great masquerader of malignancy: chronic intestinal pseudo-obstruction
Published in Biomarker research (05-12-2014)“…Paraneoplastic syndromes can precede the initial manifestation and diagnosis of cancer. Paraneoplastic syndromes are a heterogeneous group of disorders caused…”
Get full text
Journal Article -
9
HSP90 inhibitor 17AAG causes apoptosis in ATRA-resistant acute promyelocytic leukemia cells
Published in Leukemia research (01-01-2008)“…Abstract The effects of a novel heat shock protein inhibitor, 17AAG, on established APL cell lines (NB4 and R1) were analyzed. 17AAG induces apoptosis in APL…”
Get full text
Journal Article -
10
Osseous metaplasia in diffuse large B‐cell lymphoma of the kidney
Published in American journal of hematology (01-04-2007)“…A 57‐year‐old female with a history of diffuse large B‐cell lymphoma (DLBCL) presented with a renal mass. Microscopic analysis of the nephrectomy specimen…”
Get full text
Journal Article -
11
Chromosome 1 analysis in chromophobe renal cell carcinomas with tissue microarray (TMA)-facilitated fluorescence in situ hybridization (FISH) demonstrates loss of 1p/1 which is also present in renal oncocytomas
Published in Diagnostic molecular pathology (01-09-2008)“…Morphologic overlap between chromophobe renal cell carcinoma (ChRCC) and renal oncocytomas (RO) has been widely recognized. Whether these tumors are…”
Get more information
Journal Article -
12
The enigmatic role of the hemochromatosis protein (HFE) in iron absorption
Published in Trends in molecular medicine (01-03-2003)“…The HFE gene, a member of the class-I transplantation antigen gene family, is responsible for hereditary hemochromatosis, one of the most common inherited…”
Get full text
Journal Article -
13
Hemochromatosis Protein (HFE) and Tumor Necrosis Factor Receptor 2 (TNFR2) Influence Tissue Iron Levels: Elements of a Common Gut Pathway?
Published in Blood cells, molecules, & diseases (01-11-2002)“…ABSTRACT Quantitative genetic analysis of hepatic and splenic iron levels in recombinant inbred mice yielded a quantitative trait locus that was found to…”
Get full text
Journal Article -
14
Analysis of In Vitro Effects of Bortezomib (Velcade) on T Cell Prolymphocytic Leukemia (T-PLL)
Published in Blood (16-11-2006)“…T-cell prolymphocytic leukemia (T-PLL) is an aggressive lymphoproliferative disorder with postthymic T cell phenotype and prolymphocytic morphology. In the…”
Get full text
Journal Article -
15
Concurrent BCL2 and MYC Protein Expression by Immunohistochemistry Determines Clinical Outcome In DLBCL Patients Treated with R-CHOP
Published in Blood (19-11-2010)“…Abstract 2005 Concurrent translocations in MYC and BCL2 determined by fluorescence in-situ hybridization (FISH), have been associated with a poor outcome in…”
Get full text
Journal Article -
16
Virulence of a Salmonella typhimuriumOmpD Mutant
Published in Infection and Immunity (01-01-1998)“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
17
Virulence of a Salmonella typhimurium OmpD mutant
Published in Infection and immunity (1998)“…An ompD mutation caused by a Tn10 insertion was transduced into Salmonella typhimurium SL1344 and UK-1. The adherence and invasion capabilities of the…”
Get full text
Journal Article -
18
The great masquerader of malignancy: chronic intestinal pseudo-obstruction
Published in Biomarker research (01-01-2014)Get full text
Report -
19
Isolated MYC cytogenetic abnormalities in diffuse large B-cell lymphoma do not predict an adverse clinical outcome
Published in Leukemia & Lymphoma (02-11-2015)“…In this study, we investigated the significance of MYC, BCL2 and BCL6 gene abnormalities in a cohort of 205 diffuse large B-cell lymphoma (DLBCL) patients…”
Get full text
Report